EXOGENOUS PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE REDUCES MORTALITY IN MICE WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS
Rachel N. Gomes(Fundação Oswaldo Cruz), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Rosa C. S. Vianna(Hospital Universitário Clementino Fraga Filho), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), André Miguel Japiassú, Andréa P. Larangeira(Fundação Oswaldo Cruz), Juliana M. Gouvêa(Fundação Oswaldo Cruz), Marcela S. Bastos(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Stephen M. Prescott(MACOM (United States)), Guy A. Zimmerman(University of Utah), Rodrigo T. Amâncio(Universidade Federal do Rio de Janeiro), Diana M. Stafforini(University of Utah)
Cited by 61
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study
|Intensive Care Medicine|2004|568